Tina Papagiannopoulos

Access Unlocked Part 2: FDA Launches TEMPO Pilot To Advance Digital Health Under CMMI's ACCESS Model

FDA Initiates Removal Of Warnings On Hormone Replacement Therapy

FDA Releases Enforcement Letters Related To DTC Advertising

FDA Outlines "Priorities For A New FDA"

Fate Of LDT Final Rule Sealed As Appeal Deadline Passes

Court Strikes Down FDA's Final Rule On Laboratory-Developed Tests